Skip to main content
Home
  • About us
    • At a Glance
    • Leadership
    • Strategy
    • Partnerships
    • Global Network
    • History
    • Corporate responsibility
  • Patients
    • Allergic diseases
    • Allergy diagnosis
    • Allergy treatments
    • Allergy immunotherapy
    • Patient Services
  • Products
    • Our commitment to AIT
  • Innovation
    • About Innovation
    • Research
    • Clinical Development
    • Real World Evidence Study
  • Careers
    • Culture
    • Ambassadors
    • Opportunities
  • Worldwide
  • Media
    • News
    • Media Library
    • Press contacts
Home
Global
  • Global
  • Australia
  • Austria
  • Belgium
  • Canada
  • Czech republic
  • France
  • Germany
  • Italy
  • Netherlands
  • New Zealand
  • Poland
  • Russia
  • Slovakia
  • Spain
  • Swiss
  • USA

Stay up to date with the latest news from Stallergenes Greer

For more information,
visit our press room
  1. News
  2. News (old)

News (old)

  • October 25, 2017

    Stallergenes Greer invests in Adeo Health Science, a research-driven food company with a novel approach in food allergy

    Read more
  • October 25, 2017

    Stallergenes Greer’s 2017 Innovation Day

    Read more
  • October 02, 2017

    Stallergenes Greer acquires Canadian Medic Savoure, strengthening presence in North America

    Read more
  • September 26, 2017

    Stallergenes Greer advances its house dust mite allergy pipeline with acceptance of regulatory submission and new market approval

    Read more
  • August 31, 2017

    Stallergenes Greer reports strong first half 2017 results and narrows 2017 financial guidance

    Read more
  • July 27, 2017

    Stallergenes Greer announces completion of enrollment in largest phase III study to treat house dust mites allergy

    Read more
  • June 29, 2017

    Stallergenes Greer announces Matthias Vogt as Chief Financial Officer

    Read more
  • June 20, 2017

    Stallergenes Greer announces change of auditor

    Read more
  • June 19, 2017

    First real-world evidence shows long term benefits of sublingual immunotherapy to control allergic rhinitis and potentially prevent allergic asthma

    Read more
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • Next
  • last »

Contact us

Please note that this form is not to be used to ask any questions - technical or medical - regarding Stallergenes Greer products. Please contact your personal physician if you are a patient or you local medical representative at Stallergenes Greer if you are a heathcare professional.

In accordance with the Data Protection Act 2018 and GDPR, you have the right to access, correct, delete or port data relating to you, and you may, for legitimate reasons, oppose the use of your personal information by STALLERGENES GREER Ltd (or request such use be limited), in addition to which you may specify how STALLERGENES GREER Ltd uses your personal information after your death. You can exercise these rights by contacting our Data Privacy Officer via email at dpo.gdpr@stallergenesgreer.com, or by writing to STALLERGENES GREER, Data Privacy Officer, 6 rue Alexis de Tocqueville - 92160 ANTONY, France, providing proof of your identity. For further information about data protection, please refer to our Terms and Conditions and Personal Data Protection policy.

HOME

ABOUT US

  • AT A GLANCE
  • LEADERSHIP
  • STRATEGY
  • PARTNERSHIPS
  • GLOBAL NETWORK
  • WELCOME
  • HISTORY
  • CORPORATE RESPONSIBILITY

PATIENTS

  • ALLERGIC DISEASES
  • ALLERGY DIAGNOSIS
  • ALLERGY TREATMENTS
  • ALLERGY IMMUNOTHERAPY
  • PATIENT SERVICES

© Stallergenes Greer 2016

  • Site map
  • terms & conditions
  • Slavery statement
  • Cookie Policy
  • Privacy Policy

Still and moving imagery are for illustrative purposes only. Any person depicted is a model.

We use cookies to ensure that we give you the best experience on our website. If you want to find out more about the cookies we use and how to disable them, you can access our Cookie Policy . By continuing your visit on the website, you consent to the use of the cookies. Continue

YOU ARE LEAVING THE WWW.STALLERGENESGREER.COM WEBSITE

This link will take you to a website to which our Privacy Policy does not apply. Stallergenes Greer has no control over the contents of these sites or resources, and accepts no liability or responsibility for them or for any loss or damage that may arise from your use of them.